speb/financial-data huggingface dataset:
CBZ cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 5751000.00
CBZ balance_sheet (annual, 2025-12-31) — Net PPE: 415290000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Net PPE: 415290000.00
CBZ cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -16959000.00
CBZ cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1924000.00
CBZ balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -1107723000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -1107723000.00
CBZ balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 186870000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 186870000.00
CBZ balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 194011000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 194011000.00
CBZ balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 7141000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 7141000.00
CBZ income_statement (annual, 2025-12-31) — Normalized EBITDA: 365609000.00
CBZ income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -45158000.00
CBZ income_statement (annual, 2025-12-31) — Normalized Income: 114933502.00
CBZ income_statement (quarterly, 2025-12-31) — Normalized Income: -68675609.46
CBZ cash_flow (annual, 2025-12-31) — Operating Cash Flow: 192485000.00
CBZ cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 143639000.00
CBZ cash_flow (annual, 2025-12-31) — Operating Gains Losses: -711000.00
CBZ cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 413000.00
CBZ income_statement (annual, 2025-12-31) — Operating Income: 234010000.00
CBZ income_statement (quarterly, 2025-12-31) — Operating Income: -85158000.00
CBZ income_statement (annual, 2025-12-31) — Operating Revenue: 2757991000.00
CBZ income_statement (quarterly, 2025-12-31) — Operating Revenue: 542663000.00
CBZ balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 54380000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 54380000.00
CBZ balance_sheet (annual, 2025-12-31) — Other Current Assets: 79693000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 79693000.00
CBZ balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 66372000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 66372000.00
CBZ balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 305072000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 305072000.00
CBZ balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -3291000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -3291000.00
CBZ income_statement (annual, 2025-12-31) — Other Gand A: 121383000.00
CBZ income_statement (quarterly, 2025-12-31) — Other Gand A: 34411000.00
CBZ income_statement (annual, 2025-12-31) — Other Income Expense: 34040000.00
CBZ income_statement (quarterly, 2025-12-31) — Other Income Expense: 1130000.00
CBZ balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 539991000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 539991000.00
CBZ cash_flow (annual, 2025-12-31) — Other Non Cash Items: 13199000.00
CBZ cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 5959000.00
CBZ balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 38329000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 38329000.00
CBZ balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 17390000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 17390000.00
CBZ income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 33329000.00
CBZ income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 16043000.00
CBZ balance_sheet (annual, 2025-12-31) — Other Properties: 385523000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Other Properties: 385523000.00
CBZ balance_sheet (annual, 2025-12-31) — Other Receivables: 136701000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Other Receivables: 136701000.00
CBZ balance_sheet (annual, 2025-12-31) — Payables: 101942000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Payables: 101942000.00
CBZ balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 299476000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 299476000.00
CBZ income_statement (annual, 2025-12-31) — Pretax Income: 160835000.00
CBZ income_statement (quarterly, 2025-12-31) — Pretax Income: -110260000.00
CBZ cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
CBZ balance_sheet (annual, 2025-12-31) — Properties: 0.00
CBZ balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CBZ cash_flow (annual, 2025-12-31) — Purchase Of Business: -1625000.00
CBZ cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -1625000.00
CBZ cash_flow (annual, 2025-12-31) — Purchase Of Investment: -43375000.00
CBZ cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -7775000.00
CBZ cash_flow (annual, 2025-12-31) — Purchase Of PPE: -16959000.00
CBZ cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1924000.00
CBZ balance_sheet (annual, 2025-12-31) — Receivables: 555995000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Receivables: 555995000.00
CBZ balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -49915000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -49915000.00
CBZ income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 2402598000.00
CBZ income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 593410000.00
CBZ income_statement (annual, 2025-12-31) — Reconciled Depreciation: 98270000.00
CBZ income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 23957000.00
CBZ cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1428600000.00
CBZ cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -401100000.00
CBZ cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -167920000.00
CBZ cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -32369000.00
CBZ balance_sheet (annual, 2025-12-31) — Restricted Cash: 245271000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 245271000.00
CBZ balance_sheet (annual, 2025-12-31) — Retained Earnings: 1011566000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 1011566000.00
CBZ cash_flow (annual, 2025-12-31) — Sale Of Investment: 39691000.00
CBZ cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 8046000.00
CBZ income_statement (annual, 2025-12-31) — Selling General And Administration: 121383000.00
CBZ income_statement (quarterly, 2025-12-31) — Selling General And Administration: 34411000.00
CBZ balance_sheet (annual, 2025-12-31) — Share Issued: 144654000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Share Issued: 144654000.00
CBZ income_statement (annual, 2025-12-31) — Special Income Charges: 711000.00
CBZ income_statement (quarterly, 2025-12-31) — Special Income Charges: -14913000.00
CBZ cash_flow (annual, 2025-12-31) — Stock Based Compensation: 26004000.00
CBZ cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 6432000.00
CBZ balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1762067000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1762067000.00
CBZ balance_sheet (annual, 2025-12-31) — Tangible Book Value: -1107723000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -1107723000.00
CBZ income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 200502.00
CBZ income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -4171609.46
CBZ income_statement (annual, 2025-12-31) — Tax Provision: 45391000.00
CBZ income_statement (quarterly, 2025-12-31) — Tax Provision: -30843000.00
CBZ income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.28
CBZ income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.28
CBZ balance_sheet (annual, 2025-12-31) — Total Assets: 4409528000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Total Assets: 4409528000.00
CBZ balance_sheet (annual, 2025-12-31) — Total Capitalization: 3151619000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 3151619000.00
CBZ balance_sheet (annual, 2025-12-31) — Total Debt: 1828503000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Total Debt: 1828503000.00
CBZ balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1762067000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1762067000.00
CBZ income_statement (annual, 2025-12-31) — Total Expenses: 2523981000.00
CBZ income_statement (quarterly, 2025-12-31) — Total Expenses: 627821000.00
CBZ balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2647461000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2647461000.00
CBZ balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 3510279000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 3510279000.00
CBZ balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1911867000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1911867000.00
CBZ income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 234010000.00
CBZ income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -85158000.00
CBZ balance_sheet (annual, 2025-12-31) — Total Tax Payable: 11008000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 11008000.00
CBZ income_statement (annual, 2025-12-31) — Total Unusual Items: 711000.00
CBZ income_statement (quarterly, 2025-12-31) — Total Unusual Items: -14913000.00
CBZ income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 711000.00
CBZ income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -14913000.00
CBZ balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 3009000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 3009000.00
CBZ balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 90274000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 90274000.00
CBZ balance_sheet (annual, 2025-12-31) — Treasury Stock: 1078521000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 1078521000.00
CBZ balance_sheet (annual, 2025-12-31) — Working Capital: 163655000.00
CBZ balance_sheet (quarterly, 2025-12-31) — Working Capital: 163655000.00
CBZ income_statement (quarterly, 2026-03-31) — +Operating Expense: 29568000.00
CBZ income_statement (quarterly, 2026-03-31) — +Total Revenue: 848579000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 86743000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 510952000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1831208000.00
CBZ cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 1409000.00
CBZ income_statement (quarterly, 2026-03-31) — Basic Average Shares: 54299000.00
CBZ income_statement (quarterly, 2026-03-31) — Basic EPS: 2.98
CBZ cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 218090000.00
CBZ cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -3000000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 453954000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1458000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 28718000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 28718000.00
CBZ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -12578000.00
CBZ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -2919000.00
CBZ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -25515000.00
CBZ cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -4191000.00
CBZ cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -77295000.00
CBZ cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 49791000.00
CBZ cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 2910000.00
CBZ cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 6599000.00
CBZ cash_flow (quarterly, 2026-03-31) — Change In Payable: 45600000.00
CBZ cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -31695000.00
CBZ cash_flow (quarterly, 2026-03-31) — Change In Receivables: -214671000.00
CBZ cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 49791000.00
CBZ cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -236857000.00
CBZ cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -214671000.00
CBZ cash_flow (quarterly, 2026-03-31) — Changes In Cash: -41012000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Common Stock: 1458000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1894176000.00
CBZ cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -31590000.00
CBZ income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 622562000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 120240000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Current Assets: 1069283000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 58598000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Current Debt: 75170000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 133768000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 655902000.00
CBZ cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 7530000.00
CBZ cash_flow (quarterly, 2026-03-31) — Deferred Tax: 7530000.00
CBZ cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 23750000.00
CBZ cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 23750000.00
CBZ income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 61537000.00
CBZ income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.63
CBZ income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 161612000.00
CBZ income_statement (quarterly, 2026-03-31) — EBIT: 250388000.00
CBZ income_statement (quarterly, 2026-03-31) — EBITDA: 274138000.00
CBZ cash_flow (quarterly, 2026-03-31) — End Cash Position: 177078000.00
CBZ cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -12578000.00
CBZ cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -28515000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -1557000.00
CBZ income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 29568000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Goodwill: 2332809000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2856166000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Gross PPE: 488693000.00
CBZ income_statement (quarterly, 2026-03-31) — Gross Profit: 226017000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 60596000.00
CBZ income_statement (quarterly, 2026-03-31) — Interest Expense: 23916000.00
CBZ income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 23916000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Invested Capital: 3430549000.00
CBZ cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -2919000.00
CBZ cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 250700000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 395356000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1461203000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1856559000.00
CBZ cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 250700000.00
CBZ cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -171600000.00
CBZ cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -3163000.00
CBZ cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -31590000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Net Debt: 1507655000.00
CBZ income_statement (quarterly, 2026-03-31) — Net Income: 161612000.00
CBZ income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 161612000.00
CBZ income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 161612000.00
CBZ income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 161612000.00
CBZ income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 161612000.00
CBZ cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 161612000.00
CBZ income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 161612000.00
CBZ income_statement (quarterly, 2026-03-31) — Net Interest Income: -23916000.00
CBZ cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -460000.00
CBZ cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 79100000.00
CBZ cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 79100000.00
CBZ income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -23916000.00
CBZ cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -60088000.00
CBZ cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 3704000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Net PPE: 488693000.00
CBZ cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -3000000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -961990000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 181515000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 211092000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 29577000.00
CBZ income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 216183000.00
CBZ income_statement (quarterly, 2026-03-31) — Normalized Income: 120232130.00
CBZ cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -25515000.00
CBZ income_statement (quarterly, 2026-03-31) — Operating Income: 196449000.00
CBZ income_statement (quarterly, 2026-03-31) — Operating Revenue: 848579000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 54299000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 77639000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 75170000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 254555000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -1557000.00
CBZ income_statement (quarterly, 2026-03-31) — Other Gand A: 29568000.00
CBZ income_statement (quarterly, 2026-03-31) — Other Income Expense: 53939000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 523357000.00
CBZ cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 2381000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 34303000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 9054000.00
CBZ income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -4016000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Other Properties: 488693000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Other Receivables: 308584000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Payables: 147339000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 267579000.00
CBZ income_statement (quarterly, 2026-03-31) — Pretax Income: 226472000.00
CBZ cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -3495000.00
CBZ cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -4100000.00
CBZ cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -3000000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Receivables: 769442000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Receivables Adjustments Allowances: -50094000.00
CBZ income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 622562000.00
CBZ income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 23750000.00
CBZ cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -171600000.00
CBZ cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -31590000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 193484000.00
CBZ income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: -57955000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1173178000.00
CBZ cash_flow (quarterly, 2026-03-31) — Sale Of Business: 332000.00
CBZ cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 3640000.00
CBZ income_statement (quarterly, 2026-03-31) — Selling General And Administration: 29568000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Share Issued: 145734000.00
CBZ income_statement (quarterly, 2026-03-31) — Special Income Charges: 57955000.00
CBZ cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 14660000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1894176000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -961990000.00
CBZ income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 16575130.00
CBZ income_statement (quarterly, 2026-03-31) — Tax Provision: 64860000.00
CBZ income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.29
CBZ balance_sheet (quarterly, 2026-03-31) — Total Assets: 4629960000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 3355379000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Total Debt: 1990327000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1894176000.00
CBZ income_statement (quarterly, 2026-03-31) — Total Expenses: 652130000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2735784000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3560677000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2079882000.00
CBZ income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 196449000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 60596000.00
CBZ income_statement (quarterly, 2026-03-31) — Total Unusual Items: 57955000.00
CBZ income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 57955000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 3177000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 91435000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 1110111000.00
CBZ balance_sheet (quarterly, 2026-03-31) — Working Capital: 413381000.00
CC cash_flow (annual, 2021-12-31) — Amortization Cash Flow: 8000000.00
CC cash_flow (annual, 2021-12-31) — Amortization Of Intangibles: 8000000.00
CC balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 3000000.00
CC balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 3000000.00
CC balance_sheet (annual, 2021-12-31) — Investments In Other Ventures Under Equity Method: 169000000.00
CC balance_sheet (annual, 2021-12-31) — Investmentsin Associatesat Cost: 169000000.00
CC cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
CC cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
CC balance_sheet (annual, 2021-12-31) — Non Current Deferred Revenue: 2000000.00
CC balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 83000000.00
CC balance_sheet (annual, 2021-12-31) — Prepaid Assets: 75000000.00
CC cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
CC cash_flow (annual, 2021-12-31) — Purchase Of Investment: -12000000.00
CC cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
CC cash_flow (annual, 2021-12-31) — Short Term Debt Payments: 0.00
CC income_statement (annual, 2022-12-31) — +Operating Expense: 830000000.00
CC income_statement (annual, 2022-12-31) — +Total Revenue: 6831000000.00
CC balance_sheet (annual, 2022-12-31) — Accounts Payable: 1210000000.00
CC balance_sheet (annual, 2022-12-31) — Accounts Receivable: 509000000.00
CC balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -6216000000.00
CC balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1016000000.00
CC balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -10000000.00
CC cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 5000000.00
CC cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 5000000.00
CC cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
CC income_statement (annual, 2022-12-31) — Basic Average Shares: 150046614.00
CC income_statement (annual, 2022-12-31) — Basic EPS: 3.72
CC cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1551000000.00
CC balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 1180000000.00
CC cash_flow (annual, 2022-12-31) — Capital Expenditure: -307000000.00
CC balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 247000000.00
CC balance_sheet (annual, 2022-12-31) — Capital Stock: 2000000.00
CC balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1102000000.00
CC balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1102000000.00
CC cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -154000000.00
CC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -686000000.00
CC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -284000000.00
CC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 755000000.00
CC cash_flow (annual, 2022-12-31) — Change In Account Payable: 105000000.00
CC cash_flow (annual, 2022-12-31) — Change In Inventory: -294000000.00
CC cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -96000000.00
CC cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 91000000.00
CC cash_flow (annual, 2022-12-31) — Change In Payable: 105000000.00
CC cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 105000000.00
CC cash_flow (annual, 2022-12-31) — Change In Receivables: 91000000.00
CC cash_flow (annual, 2022-12-31) — Change In Working Capital: -103000000.00
CC cash_flow (annual, 2022-12-31) — Changes In Cash: -215000000.00
CC balance_sheet (annual, 2022-12-31) — Common Stock: 2000000.00
CC cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -154000000.00
CC balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1107000000.00
CC cash_flow (annual, 2022-12-31) — Common Stock Payments: -495000000.00
CC balance_sheet (annual, 2022-12-31) — Construction In Progress: 324000000.00
CC income_statement (annual, 2022-12-31) — Cost Of Revenue: 5215000000.00
CC balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 222000000.00
CC balance_sheet (annual, 2022-12-31) — Current Assets: 3214000000.00
CC balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 49000000.00
CC balance_sheet (annual, 2022-12-31) — Current Debt: 43000000.00
CC balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 92000000.00
CC balance_sheet (annual, 2022-12-31) — Current Liabilities: 1891000000.00
CC balance_sheet (annual, 2022-12-31) — Current Provisions: 204000000.00
CC cash_flow (annual, 2022-12-31) — Deferred Income Tax: 20000000.00
CC cash_flow (annual, 2022-12-31) — Deferred Tax: 20000000.00
CC balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 50000000.00
CC cash_flow (annual, 2022-12-31) — Depreciation: 286000000.00
CC cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 291000000.00
CC cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 291000000.00
CC income_statement (annual, 2022-12-31) — Diluted Average Shares: 158303007.00
CC income_statement (annual, 2022-12-31) — Diluted EPS: 3.65
CC income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 578000000.00
CC income_statement (annual, 2022-12-31) — EBIT: 904000000.00
CC income_statement (annual, 2022-12-31) — EBITDA: 1195000000.00
CC income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 55000000.00
CC cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -22000000.00
CC cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -32000000.00
CC balance_sheet (annual, 2022-12-31) — Employee Benefits: 82000000.00
CC cash_flow (annual, 2022-12-31) — End Cash Position: 1304000000.00
CC cash_flow (annual, 2022-12-31) — Financing Cash Flow: -686000000.00
CC balance_sheet (annual, 2022-12-31) — Finished Goods: 910000000.00
CC cash_flow (annual, 2022-12-31) — Free Cash Flow: 448000000.00
CC income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 21000000.00
CC income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -15000000.00
CC balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -343000000.00
CC balance_sheet (annual, 2022-12-31) — Goodwill: 102000000.00
CC balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 115000000.00
CC balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 519000000.00
CC balance_sheet (annual, 2022-12-31) — Gross PPE: 9627000000.00
CC income_statement (annual, 2022-12-31) — Gross Profit: 1616000000.00
CC income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CC cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 131000000.00
CC balance_sheet (annual, 2022-12-31) — Income Tax Payable: 19000000.00
CC income_statement (annual, 2022-12-31) — Interest Expense: 163000000.00
CC income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 163000000.00
CC cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 164000000.00
CC balance_sheet (annual, 2022-12-31) — Interest Payable: 17000000.00
CC balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -378000000.00
CC balance_sheet (annual, 2022-12-31) — Inventory: 1404000000.00
CC balance_sheet (annual, 2022-12-31) — Invested Capital: 4740000000.00
CC cash_flow (annual, 2022-12-31) — Investing Cash Flow: -284000000.00
CC balance_sheet (annual, 2022-12-31) — Investments And Advances: 175000000.00
CC balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 175000000.00
CC balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 175000000.00
CC cash_flow (annual, 2022-12-31) — Issuance Of Debt: 105000000.00
CC balance_sheet (annual, 2022-12-31) — Land And Improvements: 102000000.00
CC balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 198000000.00
CC balance_sheet (annual, 2022-12-31) — Long Term Debt: 3590000000.00
CC balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3788000000.00
CC cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 105000000.00
CC cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -185000000.00
CC balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 175000000.00
CC balance_sheet (annual, 2022-12-31) — Long Term Provisions: 547000000.00
CC balance_sheet (annual, 2022-12-31) — Minority Interest: 0.00
CC income_statement (annual, 2022-12-31) — Minority Interests: 0.00
CC cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -495000000.00
CC balance_sheet (annual, 2022-12-31) — Net Debt: 2531000000.00
CC income_statement (annual, 2022-12-31) — Net Income: 578000000.00
CC income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 578000000.00
CC income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 578000000.00
CC income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 578000000.00
CC income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 578000000.00
CC cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 578000000.00
CC income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 578000000.00
CC income_statement (annual, 2022-12-31) — Net Interest Income: -163000000.00
CC cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 3000000.00
CC cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -80000000.00
CC cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -80000000.00
CC income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -163000000.00
CC cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -8000000.00
CC cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 20000000.00
CC balance_sheet (annual, 2022-12-31) — Net PPE: 3411000000.00
CC cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -307000000.00
CC cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
CC balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 992000000.00
CC balance_sheet (annual, 2022-12-31) — Non Current Accrued Expenses: 55000000.00
CC balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 152000000.00
CC balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 61000000.00
CC balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 152000000.00
CC balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 61000000.00
CC income_statement (annual, 2022-12-31) — Normalized EBITDA: 1196000000.00
CC income_statement (annual, 2022-12-31) — Normalized Income: 578780000.00
CC cash_flow (annual, 2022-12-31) — Operating Cash Flow: 755000000.00
CC cash_flow (annual, 2022-12-31) — Operating Gains Losses: -41000000.00
CC income_statement (annual, 2022-12-31) — Operating Income: 786000000.00
CC income_statement (annual, 2022-12-31) — Operating Revenue: 6831000000.00
CC balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 148504030.00
CC balance_sheet (annual, 2022-12-31) — Other Current Assets: 82000000.00
CC balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 43000000.00
CC balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 90000000.00
CC balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -343000000.00
CC income_statement (annual, 2022-12-31) — Other Income Expense: 118000000.00
CC balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 13000000.00
CC cash_flow (annual, 2022-12-31) — Other Non Cash Items: -17000000.00
CC balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 523000000.00
CC balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 109000000.00
CC income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 64000000.00
CC income_statement (annual, 2022-12-31) — Other Operating Expenses: 2000000.00
CC balance_sheet (annual, 2022-12-31) — Other Properties: 7985000000.00
CC balance_sheet (annual, 2022-12-31) — Other Receivables: 29000000.00
CC income_statement (annual, 2022-12-31) — Other Special Charges: -7000000.00
CC balance_sheet (annual, 2022-12-31) — Payables: 1252000000.00
CC balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1474000000.00
CC cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 9000000.00
CC balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 121000000.00
CC income_statement (annual, 2022-12-31) — Pretax Income: 741000000.00
CC cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 51000000.00
CC balance_sheet (annual, 2022-12-31) — Properties: 36000000.00
CC cash_flow (annual, 2022-12-31) — Purchase Of PPE: -307000000.00
CC balance_sheet (annual, 2022-12-31) — Raw Materials: 654000000.00
CC balance_sheet (annual, 2022-12-31) — Receivables: 626000000.00
CC income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 5215000000.00
CC income_statement (annual, 2022-12-31) — Reconciled Depreciation: 291000000.00
CC cash_flow (annual, 2022-12-31) — Repayment Of Debt: -185000000.00
CC cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -495000000.00
CC income_statement (annual, 2022-12-31) — Research And Development: 118000000.00
CC balance_sheet (annual, 2022-12-31) — Restricted Cash: 0.00
CC income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 14000000.00
CC balance_sheet (annual, 2022-12-31) — Retained Earnings: 2170000000.00
CC income_statement (annual, 2022-12-31) — Selling General And Administration: 710000000.00
CC balance_sheet (annual, 2022-12-31) — Share Issued: 195375810.00
CC cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
CC cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
CC income_statement (annual, 2022-12-31) — Special Income Charges: 14000000.00
CC cash_flow (annual, 2022-12-31) — Stock Based Compensation: 27000000.00
CC balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1107000000.00
CC balance_sheet (annual, 2022-12-31) — Tangible Book Value: 992000000.00
CC income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -220000.00
CC income_statement (annual, 2022-12-31) — Tax Provision: 163000000.00
CC income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.22
CC balance_sheet (annual, 2022-12-31) — Taxes Receivable: 88000000.00
CC balance_sheet (annual, 2022-12-31) — Total Assets: 7640000000.00
CC balance_sheet (annual, 2022-12-31) — Total Capitalization: 4697000000.00
CC balance_sheet (annual, 2022-12-31) — Total Debt: 3880000000.00
CC balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1107000000.00
CC income_statement (annual, 2022-12-31) — Total Expenses: 6045000000.00
CC balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 6533000000.00
CC balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 4426000000.00
CC balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 4642000000.00
CC balance_sheet (annual, 2022-12-31) — Total Tax Payable: 42000000.00
CC income_statement (annual, 2022-12-31) — Total Unusual Items: -1000000.00
CC income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1000000.00
CC balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 46871780.00
CC balance_sheet (annual, 2022-12-31) — Treasury Stock: 1738000000.00
CC balance_sheet (annual, 2022-12-31) — Work In Process: 218000000.00
CC balance_sheet (annual, 2022-12-31) — Working Capital: 1323000000.00
CC income_statement (annual, 2023-12-31) — +Operating Expense: 1425000000.00
CC income_statement (annual, 2023-12-31) — +Total Revenue: 6078000000.00
CC balance_sheet (annual, 2023-12-31) — Accounts Payable: 1134000000.00
CC balance_sheet (annual, 2023-12-31) — Accounts Receivable: 509000000.00
CC balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -6196000000.00
CC balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1033000000.00
CC balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -2000000.00
CC cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 10000000.00
CC cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 10000000.00
CC cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
CC income_statement (annual, 2023-12-31) — Basic Average Shares: 148912397.00
CC income_statement (annual, 2023-12-31) — Basic EPS: -1.70
CC cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1304000000.00
CC balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 1180000000.00
CC cash_flow (annual, 2023-12-31) — Capital Expenditure: -370000000.00
CC balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 261000000.00
CC balance_sheet (annual, 2023-12-31) — Capital Stock: 2000000.00
CC balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 1203000000.00
CC balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 1203000000.00
CC cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -149000000.00
CC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 172000000.00
CC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -229000000.00
CC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 556000000.00
CC cash_flow (annual, 2023-12-31) — Change In Account Payable: -74000000.00
CC cash_flow (annual, 2023-12-31) — Change In Inventory: 61000000.00
CC cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 0.00
CC cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 645000000.00
CC cash_flow (annual, 2023-12-31) — Change In Payable: -74000000.00
CC cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -74000000.00
CC cash_flow (annual, 2023-12-31) — Change In Receivables: -14000000.00
CC cash_flow (annual, 2023-12-31) — Change In Working Capital: 618000000.00
CC cash_flow (annual, 2023-12-31) — Changes In Cash: 499000000.00
CC balance_sheet (annual, 2023-12-31) — Common Stock: 2000000.00
CC cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -149000000.00
CC balance_sheet (annual, 2023-12-31) — Common Stock Equity: 737000000.00
CC cash_flow (annual, 2023-12-31) — Common Stock Payments: -69000000.00
CC balance_sheet (annual, 2023-12-31) — Construction In Progress: 450000000.00
CC income_statement (annual, 2023-12-31) — Cost Of Revenue: 4776000000.00
CC balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 957000000.00
CC balance_sheet (annual, 2023-12-31) — Current Assets: 3835000000.00
CC balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 55000000.00
CC balance_sheet (annual, 2023-12-31) — Current Debt: 51000000.00
CC balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 106000000.00
CC balance_sheet (annual, 2023-12-31) — Current Liabilities: 2486000000.00
CC balance_sheet (annual, 2023-12-31) — Current Provisions: 147000000.00
CC cash_flow (annual, 2023-12-31) — Deferred Income Tax: -143000000.00
CC cash_flow (annual, 2023-12-31) — Deferred Tax: -143000000.00
CC balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 57000000.00
CC cash_flow (annual, 2023-12-31) — Depreciation: 297000000.00
CC cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 309000000.00
CC cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 309000000.00
CC income_statement (annual, 2023-12-31) — Diluted Average Shares: 148912397.00
CC income_statement (annual, 2023-12-31) — Diluted EPS: -1.70
CC income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -253000000.00
CC income_statement (annual, 2023-12-31) — EBIT: -110000000.00
CC income_statement (annual, 2023-12-31) — EBITDA: 199000000.00
CC income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 45000000.00
CC cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 11000000.00
CC cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 4000000.00
CC balance_sheet (annual, 2023-12-31) — Employee Benefits: 75000000.00
CC cash_flow (annual, 2023-12-31) — End Cash Position: 1807000000.00
CC cash_flow (annual, 2023-12-31) — Financing Cash Flow: 172000000.00
CC balance_sheet (annual, 2023-12-31) — Finished Goods: 770000000.00
CC cash_flow (annual, 2023-12-31) — Free Cash Flow: 186000000.00
CC income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 110000000.00
CC income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -38000000.00
CC balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -274000000.00
CC balance_sheet (annual, 2023-12-31) — Goodwill: 102000000.00
CC balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 105000000.00
CC balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 511000000.00
CC balance_sheet (annual, 2023-12-31) — Gross PPE: 9672000000.00
CC income_statement (annual, 2023-12-31) — Gross Profit: 1302000000.00
CC income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
CC cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 63000000.00
CC balance_sheet (annual, 2023-12-31) — Income Tax Payable: 28000000.00
CC income_statement (annual, 2023-12-31) — Interest Expense: 208000000.00
CC income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 208000000.00
CC cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 223000000.00
CC balance_sheet (annual, 2023-12-31) — Interest Payable: 18000000.00
CC balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -382000000.00
CC balance_sheet (annual, 2023-12-31) — Inventory: 1352000000.00
CC balance_sheet (annual, 2023-12-31) — Invested Capital: 4775000000.00
CC cash_flow (annual, 2023-12-31) — Investing Cash Flow: -229000000.00
CC balance_sheet (annual, 2023-12-31) — Investments And Advances: 158000000.00
CC cash_flow (annual, 2023-12-31) — Issuance Of Debt: 771000000.00
CC balance_sheet (annual, 2023-12-31) — Land And Improvements: 94000000.00
CC balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 206000000.00
CC balance_sheet (annual, 2023-12-31) — Long Term Debt: 3987000000.00
CC balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 4193000000.00
CC cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 771000000.00
CC cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -378000000.00
CC balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 158000000.00
CC balance_sheet (annual, 2023-12-31) — Long Term Provisions: 528000000.00
CC balance_sheet (annual, 2023-12-31) — Minority Interest: 2000000.00
CC income_statement (annual, 2023-12-31) — Minority Interests: -1000000.00
CC cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -69000000.00
CC balance_sheet (annual, 2023-12-31) — Net Debt: 2835000000.00
CC income_statement (annual, 2023-12-31) — Net Income: -253000000.00
CC income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -253000000.00
CC income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -252000000.00
CC income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -253000000.00
CC income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -253000000.00
CC cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -252000000.00
CC income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -252000000.00
CC income_statement (annual, 2023-12-31) — Net Interest Income: -208000000.00
CC cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -8000000.00
CC cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 393000000.00
CC cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 393000000.00
CC income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -208000000.00
CC cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -22000000.00
CC cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 149000000.00
CC balance_sheet (annual, 2023-12-31) — Net PPE: 3476000000.00
CC cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -370000000.00
CC balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 632000000.00
CC balance_sheet (annual, 2023-12-31) — Non Current Accrued Expenses: 73000000.00
CC balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 303000000.00
CC balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 44000000.00
CC balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 303000000.00
CC balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 44000000.00
CC income_statement (annual, 2023-12-31) — Normalized EBITDA: 250000000.00
CC income_statement (annual, 2023-12-31) — Normalized Income: -212608000.00
CC cash_flow (annual, 2023-12-31) — Operating Cash Flow: 556000000.00
CC cash_flow (annual, 2023-12-31) — Operating Gains Losses: -89000000.00
CC income_statement (annual, 2023-12-31) — Operating Income: -123000000.00
CC income_statement (annual, 2023-12-31) — Operating Revenue: 6078000000.00
CC balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 148587397.00
CC balance_sheet (annual, 2023-12-31) — Other Current Assets: 66000000.00
CC balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 51000000.00
CC balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -274000000.00